204 related articles for article (PubMed ID: 30081964)
61. Melting curve analysis in canine lymphoma by calculating maximum fluorescence decrease.
Schöpper I; Ohmura S; Rütgen B; Tsujimoto H; Weber K; Hirschberger J
Vet Comp Oncol; 2017 Jun; 15(2):563-575. PubMed ID: 26960964
[TBL] [Abstract][Full Text] [Related]
62. Canine idiopathic dilated cardiomyopathy. Part I: Aetiology, clinical characteristics, epidemiology and pathology.
Tidholm A; Häggström J; Borgarelli M; Tarducci A
Vet J; 2001 Sep; 162(2):92-107. PubMed ID: 11531394
[TBL] [Abstract][Full Text] [Related]
63. Case-control study of canine malignant lymphoma: positive association with dog owner's use of 2,4-dichlorophenoxyacetic acid herbicides.
Hayes HM; Tarone RE; Cantor KP; Jessen CR; McCurnin DM; Richardson RC
J Natl Cancer Inst; 1991 Sep; 83(17):1226-31. PubMed ID: 1870148
[TBL] [Abstract][Full Text] [Related]
64. An epidemiological analysis of a canine-biopsies database compiled by a diagnostic histopathology service.
Richards HG; McNeil PE; Thompson H; Reid SW
Prev Vet Med; 2001 Sep; 51(1-2):125-36. PubMed ID: 11530199
[TBL] [Abstract][Full Text] [Related]
65. Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation.
Aresu L; Martini V; Rossi F; Vignoli M; Sampaolo M; Aricò A; Laganga P; Pierini A; Frayssinet P; Mantovani R; Marconato L
Vet Comp Oncol; 2015 Dec; 13(4):348-62. PubMed ID: 23782432
[TBL] [Abstract][Full Text] [Related]
66. DNA repair deficiency as a susceptibility marker for spontaneous lymphoma in golden retriever dogs: a case-control study.
Thamm DH; Grunerud KK; Rose BJ; Vail DM; Bailey SM
PLoS One; 2013; 8(7):e69192. PubMed ID: 23935952
[TBL] [Abstract][Full Text] [Related]
67. Identification of altered MicroRNA expression in canine lymphoid cell lines and cases of B- and T-Cell lymphomas.
Uhl E; Krimer P; Schliekelman P; Tompkins SM; Suter S
Genes Chromosomes Cancer; 2011 Nov; 50(11):950-67. PubMed ID: 21910161
[TBL] [Abstract][Full Text] [Related]
68. Epidemiology and clinical presentation of canine cataracts in France: a retrospective study of 404 cases.
Donzel E; Arti L; Chahory S
Vet Ophthalmol; 2017 Mar; 20(2):131-139. PubMed ID: 27061240
[TBL] [Abstract][Full Text] [Related]
69. Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression.
Martini V; Cozzi M; Aricò A; Dalla Rovere G; Poggi A; Albonico F; Mortarino M; Ciusani E; Aresu L; Comazzi S
Vet Immunol Immunopathol; 2017 May; 187():14-19. PubMed ID: 28494924
[TBL] [Abstract][Full Text] [Related]
70. Canine diabetes mellitus: from phenotype to genotype.
Catchpole B; Kennedy LJ; Davison LJ; Ollier WE
J Small Anim Pract; 2008 Jan; 49(1):4-10. PubMed ID: 17617163
[TBL] [Abstract][Full Text] [Related]
71. Treatment of canine non-indolent T cell lymphoma using the VELCAP-TSC protocol: A retrospective evaluation of 70 dogs (2003-2013).
Goodman IH; Moore AS; Frimberger AE
Vet J; 2016 May; 211():39-44. PubMed ID: 27017053
[TBL] [Abstract][Full Text] [Related]
72. A case-control study of the risk factors for canine juvenile-onset generalized demodicosis in the USA.
Plant JD; Lund EM; Yang M
Vet Dermatol; 2011 Feb; 22(1):95-9. PubMed ID: 20707860
[TBL] [Abstract][Full Text] [Related]
73. Environmental exposures and lymphoma risk: a nested case-control study using the Golden Retriever Lifetime Study cohort.
Luethcke KR; Trepanier LA; Tindle AN; Labadie JD
Canine Med Genet; 2022 Jul; 9(1):10. PubMed ID: 35841115
[TBL] [Abstract][Full Text] [Related]
74. Characterization of a low expression haplotype in canine glutathione S-transferase (GSTT1) and its prevalence in golden retrievers.
Craft S; Ekena J; Mayer B; Thamm DH; Saba C; Chun R; Trepanier LA
Vet Comp Oncol; 2018 Mar; 16(1):E61-E67. PubMed ID: 28840668
[TBL] [Abstract][Full Text] [Related]
75. Prevalence of and risk factors for increased serum levels of allergen-specific IgE in a population of Norwegian dogs.
Bjelland AA; Dolva FL; Nødtvedt A; Sævik BK
Acta Vet Scand; 2014 Dec; 56(1):81. PubMed ID: 25475748
[TBL] [Abstract][Full Text] [Related]
76. Specific immunotypes of canine T cell lymphoma are associated with different outcomes.
Deravi N; Berke O; Woods JP; Bienzle D
Vet Immunol Immunopathol; 2017 Sep; 191():5-13. PubMed ID: 28895866
[TBL] [Abstract][Full Text] [Related]
77. Effect of signalment on the presentation of canine patients suffering from cranial cruciate ligament disease.
Guthrie JW; Keeley BJ; Maddock E; Bright SR; May C
J Small Anim Pract; 2012 May; 53(5):273-7. PubMed ID: 22489873
[TBL] [Abstract][Full Text] [Related]
78. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
Milner RJ; Pearson J; Nesbit JW; Close P
Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
[TBL] [Abstract][Full Text] [Related]
79. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
80. Clinical characteristics, breed differences, and quality of life in North American dogs with acute steroid-responsive meningitis-arteritis.
Lau J; Nettifee JA; Early PJ; Mariani CL; Olby NJ; Muñana KR
J Vet Intern Med; 2019 Jul; 33(4):1719-1727. PubMed ID: 31175683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
